1 – 25 of 25
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The HLA region in ANCA-associated vasculitis : characterisation of genetic associations in a Scandinavian patient population
(
- Contribution to journal › Article
- 2023
-
Mark
Results of the first nationwide cohort study of outcomes in dialysis and kidney transplant patients before and after vaccination for COVID-19
(
- Contribution to journal › Article
-
Mark
The management of lupus nephritis as proposed by EULAR/ERA 2019 versus KDIGO 2021
2023) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 38(3). p.551-561(
- Contribution to journal › Article
-
Mark
Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations
(
- Contribution to journal › Scientific review
-
Mark
Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction : a multicentre study
(
- Contribution to journal › Article
-
Mark
Stratified Genetic Analysis Reveals Sex Differences In MPO-ANCA-associated Vasculitis
(
- Contribution to journal › Article
- 2022
-
Mark
The management of membranous nephropathy—an update
(
- Contribution to journal › Article
-
Mark
Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease : An Open-Label Phase 2a Study
(
- Contribution to journal › Article
-
Mark
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases : consensus statements from the ERA-IWG and EUVAS
(
- Contribution to journal › Scientific review
-
Mark
Identification and Functional Characterization of a Novel Susceptibility Locus for Small Vessel Vasculitis with MPO-ANCA
(
- Contribution to journal › Article
- 2021
-
Mark
COVID-19 and ANCA-associated vasculitis : Recommendations for vaccine preparedness and the use of rituximab
(
- Contribution to journal › Letter
-
Mark
Rituximab in Membranous Nephropathy
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic
(
- Contribution to journal › Article
-
Mark
Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis
(
- Contribution to journal › Article
-
Mark
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Manifest för lämplig styrning av hälso- och sjukvården
(
- Contribution to journal › Debate/Note/Editorial
- 2017
-
Mark
Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Letter
- 2015
-
Mark
Outcome and Treatment of Elderly Patients with ANCA-Associated Vasculitis.
(
- Contribution to journal › Article
-
Mark
Slutreplik, Diana Karpman och medförfattare : - NT-rådet bör omedelbart återkalla sitt beslut om eculizumab
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
NT-rådets ställningstagande till eculizumab är oacceptabelt
(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
23 läkare om omskärelse av små pojkar : Läkarförbundet bör inta en mer odmjuk hållning
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Glomerulonephritides.
2014) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 29 Suppl 3. p.27-29(
- Contribution to journal › Published meeting abstract
- 2012
-
Mark
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up
(
- Contribution to journal › Article
-
Mark
Genetically Distinct Subsets within ANCA-Associated Vasculitis
(
- Contribution to journal › Article